title: Salvage therapy of autoimmune thrombocytopenic purpura revealing non-Hodgkin lymphoma by the thrombopoietin receptor agonist romiplostim.
authors.forename: Chadi
authors.initials: C
authors.lastname: Al-Nawakil
authors.forename: Sophie
authors.initials: S
authors.lastname: Park
authors.forename: Nicolas
authors.initials: N
authors.lastname: Chapuis
authors.forename: Francois
authors.initials: F
authors.lastname: Dreyfus
authors.forename: Tali-Anne
authors.initials: TA
authors.lastname: Szwebel
authors.forename: Laure
authors.initials: L
authors.lastname: Gibault
authors.forename: Thierry
authors.initials: T
authors.lastname: Molina
authors.forename: Olivier
authors.initials: O
authors.lastname: Hermine
authors.forename: Didier
authors.initials: D
authors.lastname: Bouscary
authors.forename: Jerome
authors.initials: J
authors.lastname: Tamburini
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000188:drug therapy; D008297:Male; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications* / Q000188:drug therapy*; D011961:Receptors, Fc / Q000627:therapeutic use*; D053628:Receptors, Thrombopoietin / Q000819:agonists*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D016879:Salvage Therapy; D013926:Thrombopoietin / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim